Minneapolis Clinical Trials
Cedar Study
Participate in a clinical study of a potential treatment for atopic dermatitis.
3 nights
12 visits
Purpose: to evaluate the safety and tolerability of an investigational medication for chronic inflammatory skin disease.
- There is one screening appointment.
- There are 3 dosing periods with separate admissions. The first dosing period has 5 overnight stays at the CRU, the second and third dosing periods have 3 overnight stays at the CRU. You will not be able to leave the CRU during these times.
- 12 planned follow-up visits.
Reimbursement for study participation will be provided for time and travel of up to $14,150.
This study has been reviewed by an independent ethics committee.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-65
BMI: 17.5-30.5 kg/m2
Medication: You must not take any medications (including over-the-counter medications, such as medications for cold or allergies, antacids, herbal supplements, St. John’s Wort, minerals, or vitamins) within 7days before the first dose
Contraception: Hormonal methods of birth control are allowed
Compensation: Up to $14,150 for study completion
Smoking: You must not use tobacco or nicotine containing products in excess of the equivalent of 5 cigarettes per day
Study Duration 541 Days